With the gradual popularization of minimally invasive sling treatment, more and more female patients with stress urinary incontinence are receiving midurethral suspension, although this procedure is currently the most effective and safe treatment for female stress urinary incontinence, midurethral suspension is still a surgical procedure to achieve urinary control in a non-physiological manner, so long-term postoperative follow-up is still required. I will briefly introduce the treatment and follow-up of female stress urinary incontinence after midurethral suspension. 1, usually the day after the operation need to check the patient both sides of the puncture wound for blood leakage, whether the crust has been, and pull out the gauze and urinary catheter filled into the vagina, and ask the patient to drink more water. 2.After the first urination, the patient should know whether there is any difficulty in urination and whether there is any obvious thinning of urine line, and those who have regulation should have post-vaginal ultrasound residual urine volume measurement. 3.On the third day after surgery, after the basic relief of the discomfort of urination, the urinary flow rate and residual urine volume measurement should be done. If both are normal, the patient can be discharged. 4.If the patient has obvious difficulty in urination or even urinary retention, a urethral probe can be inserted through the urethra and compressed downward to loosen the sling, and some patients can therefore significantly relieve the difficulty in urination. 5.If the difficulty in urination is still not relieved, a urinary catheter can be left in place for continuous drainage, and the urethra can be dilated and pressed downward with a urethral probe every day for about a week. Those who still cannot urinate by this method may have a lower chance of urinating on their own thereafter, and even if they can barely urinate, there may be too much residual urine or the urinary flow rate may be significantly reduced, which may affect the bladder function in the long run. Eventually, the sling may need to be cut vaginally and the operation may fail. 6.Postoperative puncture site pain is mostly related to local hematoma, and hot compresses can significantly reduce the pain. 7.Patients should return to the hospital for follow-up 2 weeks after discharge. The follow-up includes vaginal examination to understand the wound healing, urinary flow rate and residual urine volume measurement to understand whether there is any impairment of urinary function. 8, 3, 6, 12 months after surgery, and annually thereafter, follow-up urinary flow rate and residual urine volume measurement to understand the long-term effects of the sling on bladder function. 9.Any time a urinary tract infection, or unexplained hematuria or vaginal blood leakage occurs in a patient after midurethral suspension, prompt examination should be performed, mainly to understand whether there is urinary retention or increased residual urine volume, and whether there is erosion of the sling into the vagina. If all the above examinations are normal, cystourethroscopy should be done if necessary to understand whether there is erosion of the sling into the urethra. 10.Some patients will have urinary frequency and urgency after surgery, which may be related to surgical stimulation of the urethra or the bottom of the bladder. Generally, such symptoms will disappear about 4 weeks after surgery. If the symptoms are serious, you can take selinephrine twice a day, one tablet each time, which can effectively relieve urinary frequency and urgency, and the drug is prohibited for those with intestinal obstruction, glaucoma and intractable constipation. 11.Avoid intercourse for 1 month after surgery to prevent vaginal wound dehiscence. 12.Patients are required not to have heavy physical activities for 3 months after surgery. After 3 months, the sling will not normally slip off due to the connective tissue embedded in the sling.